Three Women Each File Power Morcellator Lawsuits Alleging the Device Spread Their Uterine Cancer

January 08, 2016 – – Banville Law reports on power morcellator lawsuits filed by three women against device manufacturer Gyrus ACMI. Their complaints all similarly allege that the Gyrus ACMI power morcellator tool used on each of them during their gynecological surgeries inherently exposed and disseminated previously unknown uterine cancer cells. The complaints were filed under three individual case numbers: 150401310, 150401312, and 150900680.

Power morcellators are medical tools used during laparoscopic gynecological surgeries such as myomectomies and hysterectomies. They remove uterine fibroids or troublesome uterine tissue. The devices gained approval by the U.S. Food and Drug Administration in 1991, and were sold across the nation just two short years later, in 1993. Many physicians and patients initially preferred using power morcellation for gynecological surgeries because the tool offered a much less invasive option to usual open surgery.

A power morcellator can be inserted into the abdomen to remove uterine fibroids through just a small incision. This offers the patient a much faster recovery time. Once inside, the tool works much like a drill. It rapidly spins blades which are designed to shred troublesome tissue and fibroids into small pieces. It has a hollow tube attached to its front which is designed to then pull tissue pieces that are shred apart up and out of the body.

According to the allegations of the women involved in these lawsuits, as well as the allegations of many other power morcellator plaintiffs across the country, as the device does this, it can uncover cancer cells which the patient and physicians may have been completely unaware of. Complaints say that not only does the device uncover these cells and expose them, it also spreads them throughout the body, leading to an aggressive, high-grade cancer diagnosis post surgery. This diagnosis is often a fatal one, due to the fact that the accelerated and spread cancer is difficult to treat.

In 2014, the U.S. Food and Drug Administration surprised physicians and the general public when they issued a safety warning announcing that power morcellators should no longer be used during gynecological surgeries involving uterine fibroids. They stated: “When used for hysterectomy or myomectomy in women with uterine fibroids, laparoscopic power morcellation poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.”

Additionally, the FDA estimated that around 1 in every 350 women who do undergo laparoscopic power morcellation for gynecological surgeries may have uterine cancer cells that are completely undetected prior to surgery. When these cells are encapsulated within a uterine fibroid, they are virtually impossible to detect.

Details of the lawsuits of these three Philadelphia women state that each underwent a power morcellation surgery to remove their uterine fibroids and each was suddenly informed post-surgery that they had uterine cancer.

The attorneys at Banville Law understand what a serious and potentially life-threatening issue this is. They are now working to ensure that any woman who has undergone laparoscopic power morcellation and has subsequently been diagnosed with cancer will have the opportunity to explore her legal rights. These women may be entitled to legal action and significant compensation. To help these women look into their options, Banville Law is currently offering free legal consultations for those who qualify.

For additional information regarding power morcellation lawsuits, or to ask questions, please contact Banville Law by calling (888) 997-3792.

###

Contact Banville Law:

Laurence Banville, Esq.
888-997-3792
info@banvillelaw.com
165 West End Avenue, #1H
New York, NY 10023
United States (US)

ReleaseID: 60007051